Back
Liberty Global Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
34
LBTYA
Liberty Global
Last Price:
21.26
Seasonality Move:
-0.42%
Sell
26
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Sell
34
Liberty Global (LBTYA)
is a Sell
Is Liberty Global a Buy, Sell or Hold?
- The current Liberty Global [LBTYA] share price is $21.28. The Score for LBTYA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- LBTYA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $55.20. The Score for RARE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LBTYA Stock Price Chart
What is Liberty Global's stock price today?
-
The Liberty Global share price today is $21.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBTYA is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $55.20
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
LBTYA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 69.8 | Buy |
Chaikin Money Flow: | 1095578 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.31 - 20.69) | Buy |
Bollinger Bands (100): | (17.15 - 19.71) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 46.4 | Sell |
Chaikin Money Flow: | -343486 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.94 - 58.24) | Sell |
Bollinger Bands (100): | (40.06 - 53.94) | Buy |
LBTYA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.81 | Buy |
20-day SMA: | 20.2 | Buy |
50-day SMA: | 19.47 | Buy |
200-day SMA: | 18.02 | Buy |
8-day EMA: | 20.82 | Buy |
20-day EMA: | 20.3 | Buy |
50-day EMA: | 19.54 | Buy |
200-day EMA: | 18.31 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.58 | Sell |
20-day SMA: | 57.08 | Sell |
50-day SMA: | 52.76 | Buy |
200-day SMA: | 46.81 | Buy |
8-day EMA: | 57.09 | Sell |
20-day EMA: | 56.67 | Sell |
50-day EMA: | 53.36 | Buy |
200-day EMA: | 47.25 | Buy |
Liberty Global Earnings Growth & LBTYA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.82 per share, and an increase next year of $0.06 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Liberty Global Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |